Search filters

List of works by Sara A Byron

A method to reduce ancestry related germline false positives in tumor only somatic variant calling

scientific article published on 19 October 2017

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

scientific article

An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine

scientific article

BM-15TARGETING MEK IS A NOVEL AND EFFECTIVE TREATMENT STRATEGY OF LUNG CNS METASTASIS.

scientific article published in November 2014

Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma

scientific article

Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features.

scientific article published on 12 October 2012

DIPG-40. PNOC-003: PRECISION MEDICINE TRIAL FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA.

scientific article published on 31 May 2017

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.

scientific article published on 26 April 2017

FGFR2 as a molecular target in endometrial cancer

scientific article published on February 2009

FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

scientific article published on 15 March 2017

FGFR2 mutations are rare across histologic subtypes of ovarian cancer

scientific article published on 27 January 2010

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

scientific article (publication date: 2012)

Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells

scientific article published in November 2012

GE-03GENOMIC CHARACTERIZATION OF SURVIVAL OUTLIERS IN GLIOBLASTOMA MULTIFORME

scientific article published in November 2014

GE-19GENOMICS GUIDED THERAPEUTIC APPROACH FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM) USING NEXT GENERATION SEQUENCING (NGS) TECHNOLOGIES

scientific article published in November 2014

HG-115PRECISION MEDICINE APPROACH FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA.

scientific article published on 30 May 2016

Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular Matrix

scientific article

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation

scientific article

Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer

scientific article

Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.

scientific article published on 17 October 2006

Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma

scientific article

Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer

scientific article

PL-03FEASIBILITY OF GENOMICS-ENABLED THERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS AND DIFFUSE PONTINE GLIOMAS.

scientific article published in November 2014

Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer

scientific article published on October 1, 2003

Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.

scientific article published on September 2008

Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status

scientific article published on 5 October 2012

The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors

scientific article published on August 2013

Toward precision medicine in glioblastoma: the promise and the challenges

scientific article published on May 2015

Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway.

scientific article published on October 2014

Translating RNA sequencing into clinical diagnostics: opportunities and challenges.

scientific article

XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts

scientific article